摘要
目的:探讨胸水中INF-γ、ADA、CEA、CA125四项指标联合检测对于鉴别良恶性胸腔积液的意义和诊断价值。方法:收集2011年1月-2012年12月在笔者所在医院治疗的136例胸腔积液患者,经病理诊断分恶性组(n=75)和良性组(n=61),检测患者的胸水中CEA、CA125和INF-γ、ADA活性,并对检测结果进行比对分析。结果:恶性组肿瘤标志物CEA、CA125水平明显高于良性组,INF-γ、ADA表达水平明显低于良性组,差异具有统计学意义(P<0.05)。联合检测可显著提高诊断敏感性(93.3%)。结论:联合检测胸水中INF-γ、ADA、CEA、CA125四项指标,对鉴别良恶性胸腔积液有重要诊断意义和临床价值。
Objective: To investigate the INF-γ, ADA、 CEA、 CA125 indicators of significance and diagnostic value for differentiating benign and malignant pleural effusion.Method: Collected 136 cases of patients with pleural effusion treated in our hospital, and divided into malignant group ( n=75 ) and benign group ( n=61 ) .Compared results of INF-γ, ADA, CEA CA125 between two groups.Result: Malignancy tumor markers CEA and CA125 level of malignant group were significantly higher than those in benign group, while INF-γ , ADA expression level were significantly lower than that in benign group, with statistically significant difference ( P〈0.05 ) .Joint detection can significantly improved the diagnostic sensitivity ( 93.3% ) . Conclusion: The joint detection of INF-γ, ADA, CEA, CA125 have important diagnostic significance and clinical value in differentiating benign and malignant plenral effusion.
出处
《中国医学创新》
CAS
2013年第13期41-42,共2页
Medical Innovation of China
关键词
胸腔积液
联合监测
诊断
Pleural effusion
Joint monitoring
Diagnosis